MedPath

Healthy Nordic Foods to Prevent Cardiometabolic Risk in Obese Subjects

Not Applicable
Completed
Conditions
Diet Modification
Obesity
Cardiovascular Risk Factor
Interventions
Other: Nordic diet
Other: Control diet
Registration Number
NCT03102853
Lead Sponsor
Lund University
Brief Summary

This project will examine whether long-term consumption of healthy Nordic foods can maintain a healthy weight also after weight loss, and decrease abdominal fat accumulation and cardiometabolic risk. The study will be performed with the aim to achieve a substantial body weight loss in the first phase by prescribing a standardized low caloric dietary formula. The follow-up phase will be a body weight-maintenance period and the subjects will be randomised to a healthy Nordic diet group and a control diet group. During the study body weight will be monitored and other measurements will include insulin sensitivity, blood lipids and inflammation markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • age 25-67 years, BMI 30-40 kg/m2, waist circumference men >102cm and women > 88cm or sagittal abdominal diameter men >22cm and women >20cm, stable body weight
Exclusion Criteria
  • glucose >7.0 mmol/l, B-Hb1aC >48 mmol/L, triglycerides >4 mmol/l, total cholesterol >8 mmol/l, bloodpressure >160/100 mmHg, chronic disease, gastro-intestinal disease, hyper-/hypothyroidism, alcohol abuse, cancer, gastric bypass operation, gluten allergy, lactose intolerance, pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nordic dietNordic diet-
Control dietControl diet-
Primary Outcome Measures
NameTimeMethod
Change in sagittal abdominal diameterChange from baseline to month 6, 12, 18, 24
Change in body weightChange from baseline to month 6, 12, 18, 24
Secondary Outcome Measures
NameTimeMethod
Insulin sensitivity (HOMA-IR)Before and after body weight loss/maintenance: baseline (week -6), 0 (after 6-week weight loss period, month 6, 12, 18, 24
Body fat and body lean mass (BIA)Before and after body weight loss/maintenance: baseline (week -6), 0 (after 6-week weight loss period, month 6, 12, 18, 24
Blood lipidsBefore and after body weight loss/maintenance: baseline (week -6), 0 (after 6-week weight loss period, month 6, 12, 18, 24
Blood pressureBefore and after body weight loss/maintenance: baseline (week -6), 0 (after 6-week weight loss period, month 6, 12, 18, 24
Markers of kidney and liver functionBefore and after body weight loss/maintenance: baseline (week -6), 0 (after 6-week weight loss period, month 6, 12, 18, 24
Markers of inflammation and endothelial functionBefore and after body weight loss/maintenance: baseline (week -6), 0 (after 6-week weight loss period, month 6, 12, 18, 24

Trial Locations

Locations (1)

Biomedical Nutrition, Lund University and Unit for Diabetesstudies, Lund University Hospital

🇸🇪

Lund, Sweden

© Copyright 2025. All Rights Reserved by MedPath